Genmab — Januar 2024
-
Det lysner for biotek i 2024 – måske https://borsen.dk/nyheder/virksomheder/det-lysner-for-biotek-i-2024-maaske?b_source=borsen&b_medium=row_0&b_campaign=list_2
-
Fra artiklen "Medicinalgiganterne viser allerede øget appetit på opkøb, og ifølge Sofinnova-chefen har de i intervallet 500-1000 mia. dollar at købe op for.
“Hvis du kombinerer, at farma har masser af kontanter med den patentkløft, der skal dækkes, så er det nødt til at give en dynamik med mere M&A,” siger Henrijette Richter."
-
Tirsdagens danske avisuddrag med biotek, fødevarer og Vestas https://www.proinvestor.com/investornyt/1097870/tirsdagens-danske-avisuddrag-med-biotek-fodevarer-og-vestas
-
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons https://www.proinvestor.com/investornyt/1098357/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons
-
https://medwatch.dk/Medicinal___Biotek/article16690019.ece Analytiker har øje på Novo Nordisk, Genmab og høreapparaterne i 2024
-
Epcoritamab for R/R FL: Matthew Hadfield, Alankrita Taneja, Tahi Ahmadi, and Jacqueline Nielsen https://www.youtube.com/watch?v=nWu7COfILhY
-
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors https://www.nature.com/articles/s41467-023-44308-6#Sec9
-
Genmab to Present at the 42nd Annual J.P. Morgan Healthcare Conference 8:15 PM CET on January 10, 2024. https://ir.genmab.com/news-releases/news-release-details/genmab-present-42nd-annual-jp-morgan-healthcare-conference
-
Recent Advances in Treating Endometrial and Cervical Cancers : Episode 13
Tisotumab Vedotin for Patients With Recurrent or Metastatic Cervical Cancer https://www.onclive.com/view/tisotumab-vedotin-for-patients-with-recurrent-or-metastatic-cervical-cancer -
Genmab nede med 3,30% i USA. NBI nede med 0,5%!
-
spekulanterne er der nok ikke mange af, aktien er ikke rigtigt shortet, de leger hvis i bava... den er hvis bare usexet unden goden nyheder den næste tid og usikkerhed omkring fremtiden efter darazalex og en voldgiftssag der stadig hænger over holdet efter 3 år
-
Godmorgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind